Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein
Abstract
A key advantage of recombinant antibody technology is the ability to optimize and tailor reagents. Single domain antibodies (sdAbs), the recombinantly produced variable domains derived from camelid and shark heavy chain antibodies, provide advantages of stability and solubility and can be further engineered to enhance their properties. In this study, we generated sdAbs specific for Ebola virus envelope glycoprotein (GP) and increased their stability to expand their utility for use in austere locals. Ebola virus is extremely virulent and causes fatal hemorrhagic fever in similar to 50 percent of the cases. The viral GP binds to host cell receptors to facilitate viral entry and thus plays a critical role in pathogenicity.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 12, 2017
- Accession Number
- AD1117776
Entities
People
- Dan Zabetakis
- Ellen R Goldman
- George P. Anderson
- Jinny L. Liu
- Lisa C Shriver-Lake
Organizations
- United States Naval Research Laboratory